![Arcellx, Inc. logo](/logos/ACLX.webp)
Arcellx, Inc.
NASDAQ:ACLX
Overview | Financials
Company Name | Arcellx, Inc. |
Symbol | ACLX |
Currency | USD |
Price | 71.25 |
Market Cap | 3,830,092,200 |
Dividend Yield | 0% |
52-week-range | 30.88 - 75.1 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Rami Elghandour |
Website | https://arcellx.com |
An error occurred while fetching data.
About Arcellx, Inc.
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD